Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2018.

“We delivered strong revenue and earnings growth in the first quarter,” said Steve Rusckowski, Chairman, President and CEO. “We grew revenue 3.7 percent despite severe winter weather and the impact of lower Medicare reimbursement under PAMA. Earnings growth was driven by our continued strong execution as well as the benefits of tax reform. Our two-point strategy of accelerating growth and driving operational excellence continues to produce results.”

To view the full earnings release, visit the Newsroom section at